We are live on ! Find out more
Creative Planning

Creative Planning Portfolio holdings

AUM $147B
1-Year Est. Return 18.73%
This Fund
S&P 500
This Quarter Est. Return
+2.62%
1 Year Est. Return
+18.73%
3 Year Est. Return
+48.71%
5 Year Est. Return
+44.71%
10 Year Est. Return
+145.34%
AUM
$29.7B
AUM Growth
+$1.97B
Cap. Flow
+$1.27B
Cap. Flow %
4.28%
Top 10 Hldgs %
54.74%
Holding
2,185
New
207
Increased
867
Reduced
691
Closed
168

Sector Composition

Rank Sector Weight
1 Financials 4.86%
2 Technology 4.06%
3 Healthcare 2.07%
4 Industrials 1.87%
5 Consumer Discretionary 1.87%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
QUAL icon
851
iShares MSCI USA Quality Factor ETF
QUAL
$45.8B
$809K ﹤0.01%
8,841
+4,904
+125% +$441K
APTV icon
852
Aptiv
APTV
$12B
$806K ﹤0.01%
9,967
+1,505
+18% +$119K
MJ icon
853
Amplify Alternative Harvest ETF
MJ
$101M
$804K ﹤0.01%
2,114
+26
+1% +$10.5K
ZGNX
854
DELISTED
Zogenix, Inc.
ZGNX
$804K ﹤0.01%
16,825
WMC
855
DELISTED
Western Asset Mortgage Capital Corporation
WMC
$803K ﹤0.01%
8,046
+100
+1% +$10.2K
CG icon
856
Carlyle Group
CG
$16.3B
$799K ﹤0.01%
35,358
+1,560
+5% +$32.1K
FLRN icon
857
State Street SPDR Bloomberg Investment Grade Floating Rate ETF
FLRN
$3.11B
$798K ﹤0.01%
25,963
+1,020
+4% +$31.3K
SBR
858
Sabine Royalty Trust
SBR
$1.08B
$797K ﹤0.01%
16,501
+1,001
+6% +$48.4K
HURC icon
859
Hurco Companies Inc
HURC
$137M
$796K ﹤0.01%
22,375
-100
-0.4% -$3.78K
SAN icon
860
Banco Santander
SAN
$194B
$792K ﹤0.01%
180,369
-6,909
-4% -$31K
MTB icon
861
M&T Bank
MTB
$36.2B
$791K ﹤0.01%
4,654
-512
-10% -$84.8K
VRSK icon
862
Verisk Analytics
VRSK
$26.4B
$788K ﹤0.01%
5,379
+419
+8% +$59.1K
ZVRA icon
863
Zevra Therapeutics
ZVRA
$563M
$788K ﹤0.01%
28,132
UBS icon
864
UBS Group
UBS
$170B
$784K ﹤0.01%
66,199
+1,695
+3% +$20.8K
HI
865
DELISTED
Hillenbrand
HI
$783K ﹤0.01%
19,789
+110
+0.6% +$4.42K
PRF icon
866
Invesco FTSE RAFI US 1000 ETF
PRF
$9.73B
$783K ﹤0.01%
33,545
+5,290
+19% +$122K
FNF icon
867
Fidelity National Financial
FNF
$13.9B
$782K ﹤0.01%
20,177
-1,050
-5% -$39.6K
PRFZ icon
868
Invesco FTSE RAFI US 1500 Small-Mid ETF
PRFZ
$2.75B
$782K ﹤0.01%
30,635
+2,595
+9% +$66.3K
WINA icon
869
Winmark
WINA
$1.19B
$782K ﹤0.01%
+4,517
New +$808K
EL icon
870
Estee Lauder
EL
$29B
$776K ﹤0.01%
4,235
+392
+10% +$67K
SHM icon
871
State Street SPDR Nuveen ICE Short Term Municipal Bond ETF
SHM
$3.47B
$774K ﹤0.01%
15,825
-471
-3% -$22.9K
STT icon
872
State Street
STT
$50.9B
$773K ﹤0.01%
13,795
-209
-1% -$13K
SM icon
873
SM Energy
SM
$7.96B
$771K ﹤0.01%
+61,598
New +$894K
HOLX
874
DELISTED
Hologic
HOLX
$769K ﹤0.01%
16,017
-501
-3% -$23.2K
ONEQ icon
875
Fidelity Nasdaq Composite Index ETF
ONEQ
$10.2B
$768K ﹤0.01%
24,400
+2,720
+13% +$84.2K

Similar funds

Creative Planning's Q2 2019 Portfolio in Review

As of Q2 2019, Creative Planning held 2,185 positions worth $29.7B, up 7.1% from $27.8B the previous quarter. Its ten largest holdings account for 55% of the portfolio.

Creative Planning deployed $1.27B of net new capital in Q2 2019, opening 207 new positions and adding to 867 existing holdings. Its largest new stake was Dow Inc: 108,999 shares worth $5.38M.

By sector, the portfolio is most concentrated in Financials at 4.9% of assets, up from 4.7% a quarter earlier, followed by Technology and Healthcare.

On the sell side, the largest reduction was Vanguard Mid-Cap ETF, an estimated $115M trimmed.

  • Creative Planning's largest Q2 2019 buy was Dow Inc: 108,999 shares worth $5.38M.
  • Creative Planning added most to iShares Core US Aggregate Bond ETF in Q2 2019, an estimated $297M increase.
  • Creative Planning's biggest Q2 2019 reduction was Vanguard Mid-Cap ETF, cutting an estimated $115M.
  • Creative Planning fully exited Intercept Pharmaceuticals, Inc. in Q2 2019, selling an estimated $3.71M.
  • Creative Planning's ten largest holdings make up 55% of its $29.7B portfolio in Q2 2019.
  • Creative Planning opened 207 new positions and closed 168 in Q2 2019.
  • Creative Planning's portfolio value rose 7.1% quarter-over-quarter to $29.7B.

Based on Creative Planning's 13F filing for Q2 2019, filed 26 Jul 2019.